Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2009 until 31st March 2010 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
ISPAH says that data from the 2009 scheme showed that 69% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
Further information and the 2010 Barren EweCheck pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
MSD Animal Health has launched Expertis Udder Health, a farm management tool for veterinary surgeons to better enable them to monitor and improve udder health in dairy cattle.
Expertis was presented to vets at the International Conference on Udder Health and Communication which took place in Utrecht this week.
Expertis Udder Health consists of a software programme together with educational and communication tools to help veterinary surgeons and farmers find the causes of mastitis more easily.
The Expertis Udder Health program consists of four steps: 1. A farm intake questionnaire about setting goals puts the farmer in a central position, and allows for careful listening in order to align with his/her objectives. 2. The data is analyzed, leading to the identification of the right focus points that are needed to identify areas for improvement. 3. These focus points are presented as fact sheets, i.e. a check list of risk factors for mastitis within the focus point. 4. The information is synthesized into an automatic summary of the actual situation, the udder health objectives and an open space to fill in the tailor-made advice to the farmer for improvement of the udder health status on his farm.
Jantijn Swinkels, DVM, Global Technical Director Pharmaceuticals within the Ruminants Business Unit at Merck Animal Health said: "The structured approach offered by Expertis Udder Health takes into account that mastitis is a multifactorial disease and covers all aspects that influence udder health. To save time, the analysis ensures that the focus is on the most important issues, which can differ greatly from farm to farm. The existing services provided within this tool can be used to optimize udder health on the farm".
Rinse Jan Boersma, MSc, Global Director Dairy Cattle at Merck Animal Health added: "We have developed Expertis to support veterinarians and farmers by improving our service level as well as to contribute to good veterinary practices by implementing preventive measures and prudent use of antibiotics."
MSD says that as a consequence of the reduced milk production, discarded milk, veterinary and treatment costs and extra labor costs, mastitis is considered the most important cause of economic loss for dairy operations. Recent data from Sweden indicates an average economic loss of €278 per case of clinical mastitis and of €60 per case of sub-clinical mastitis.*
The Expertis Udder Health program is being rolled out country to country, and will be distributed to veterinary surgeons via local MSD Animal Health representatives.
Reference
* Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 2010;4:1758-70
Boehringer Ingelheim Vetmedica is giving veterinary practices the chance to offer cat owners a free 3ml pack of Metacam to trial treatment in cats with chronic pain.
Boehringer says each free Metacam pack will provide up to seven days' pain relief to an average-sized arthritic cat, and that it comes in an easy-to-administer cat friendly syringe for accurate dosing. The company also points towards a study which demonstrates that Metacam is highly palatable in 95% of cats1.
To qualify for the offer, veterinary surgeons have to fill in a redemption form logging five new cases. The offer is limited to 25 free bottles per practice. Replacement stock will be sent via your usual veterinary wholesaler. In addition, all completed forms will be entered into a prize draw to win one of six copies of the textbook 'Feline Orthopedics'
According to Boehringer, it is estimated that up to 90% of older cats (over 12 years of age) have radiographic evidence of degenerative joint disease2. However, cats may be more restrained than dogs in the way they react to chronic OA pain, and subtle behaviour changes can be a sign that cats are suffering from chronic pain3.
For further information on Metacam and the 3ml trial pack offer, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
References
CVS has announced that it is diversifying into pet grooming, opening grooming studios in its practices across the UK.
The company says the move is in response to the large number of clients that ask its staff to recommend a groomer in their area.
The new service has been branded MiGroomers and the first four studios have been opened at The Priory Veterinary Group and The Orchard Veterinary Centre in Nottingham, at Bridge House Vets in Mansfield, and at Haygate Veterinary Centre in Telford. Further studios are opening the Old Golf House Veterinary Group in Norfolk and in the Southwold-based Fromus Veterinary Group by the end of the month.
CVS says MiGroomers studios offer a full range of grooming services, all carried out by experienced groomers, Diploma-qualified to City and Guilds Level 2 or above.
Barry Brackner, Marketing and Commercial Director at CVS, said: "Given the frequency with which we are asked to recommend local groomers, moving into this growing sector where space in our practices allows it, seems a logical next step towards providing our clients with a one-stop-shop for all of their pet care requirements.
"It also enables us to offer additional career opportunities for our staff - something which is a priority for us at CVS. All of the current MiGroomers studios are being run by existing staff with an interest and qualification in grooming so it's a win/win and initial feedback from clients has been very positive. We will open further additional MiGroomers studios where we have the interest from staff and the potential to provide the appropriate facilities."
Lax-a-Past is a palatable paste that can be administered orally to kittens and cats aged over 6 months.
It can be used weekly to help stop hairballs from forming or in higher doses over a consecutive three-day period to help eliminate them.
Carol Morgan, Brand Manager from Dechra Veterinary Products (pictured right) said: “Hairballs are a well-known issue for cats. Lax-a-Past is a complementary feed that offers a simple, easy-to-administer solution to help relieve the digestion problems caused by hairballs.
“It is very easy for owners to administer as the required dosage can be squeezed out and spread on a front paw or given directly into the mouth."
Lax-a-Past is available in a 70g tube.
For more information visit www.dechra.co.uk.
Luisa (pictured left) said: “We want to further understand the research topics and questions that UK vets believe are most critical to improving veterinary care and advancing the veterinary profession.
“We are particularly interested in the topics, issues and questions that vets think scientific evidence would help when practicing veterinary medicine, whether specific to their role or the entire profession.
"It’s vitally important to highlight potential research gaps, so we can ensure clinical studies have the greatest possible impact to help improve outcomes for our patients.”
The survey will be conducted in two parts.
The first survey will close in early March, with the second survey circulated in April for three months.
The results will be published in an online, open access peer-reviewed journal.
Survey: https://bit.ly/4ko3utN
The Pet Food Manufacturers Association (PFMA) has published the results of research which found that veterinary surgeons believe 45% of all pets are overweight.
In addition, 77% of the 180 vets surveyed at the London Vet Show 2013 believe that the pet obesity problem is on the rise.
Meanwhile, 93% of pet owners said they would be concerned to discover their pet is overweight, revealing a sharp divide between vets' and owners' perceptions.
To help spread the word about ideal pet weight, the PFMA will launch a new campaign called #GetPetsFit on 7th May.
Michael Bellingham, Chief Executive of PFMA said: "We need to engage pet owners emotionally, helping them realise that feeding and exercising their pet to the optimum level can result in an extra two years of active life. The #GetPetsFit campaign will provide the perfect opportunity to do this and we hope that with the help of vets, we can work to resolve this important issue."
The PFMA is urging practices to promote good nutrition and a healthy lifestyle. Zara Boland BVSc BE MRCVS, Founder of Vet Voice Ltd says: "It is encouraging that success rates are high for the 78% of UK vets already running companion animal obesity clinics. However, we must continue pushing the health message until overweight pets are no longer seen as the 'norm'. We need widespread recognition of pet obesity to pave the way for positive action."
One way that the PFMA is encouraging practices to get involved is by running Weigh in Wednesdays from 7th May. To help, the organisation has prepared a free kit that contains campaign posters, website banners and client hand-out materials, including Pet Size-O-Meters (for cats, dogs, rabbits and birds), a pet food diary and weight and body condition log. You can either download the kit here: www.pfma.org.uk/weighinwednesday or visit PFMA's homepage and ask for a free pack to be sent to your practice.
The Equine Veterinary Journal (EVJ) has published a free online collection of articles which explain the current understanding of equine antimicrobial resistance and how the profession can preserve the effectiveness of these essential medicines.
The new collection comprises ten clinical reports and studies and three editorials covering current trends on bacterial populations, risk factors and the appropriate use of antimicrobials in practice.
A clinical report on the changes in bacterial populations in foals with sepsis raises the question whether the emergence of resistance in horses has occurred as a result of antibiotic use in humans, with nosocomial spread from human handlers in foals. Studies on the prevalence of faecal carriage of antimicrobial resistant E. coli show their prevalence to be common in normal horses in the community in the UK, although MRSA carriage was rare. Data suggested transmission of resistant bacteria from animals receiving antibiotics may result in carriage of bacteria by in contact animals.
The need for judicious use of antimicrobials is reinforced in a study on antimicrobial-associated diarrhoea in three equine referral practices. Two papers investigate both prescribing practice in the UK and the impact of antimicrobial use on infection and pyrexia in hospitalised horses, concluding that there are opportunities for more targeted, ‘smart’, use antimicrobials in the perioperative period, rather than simply more antimicrobials.
The final study discusses a low-cost syndromic surveillance model for monitoring healthcare associated infection in clinical practice to provide a realistic benchmark against which other hospitals may compare antimicrobial study data.
Three supporting editorials complete the online collection, giving comment on the overall situation of antimicrobial resistance in the horses, including the current political situation and antimicrobials and surgical site infection.
Professor Peter Clegg, Associate Editor of the Equine Veterinary Journal said: "It remains to be determined how big a problem antimicrobial resistance will become for the equine veterinary profession, either through greater difficulties in treating horses, or through political pressure to restrict access to antimicrobials. Meanwhile the EVJ remains committed to the promotion of responsible stewardship to best preserve the efficacy of the drugs we have got for as long as we can."
Mark Bowen, President of the British Equine Veterinary Association and guest editor said: "BEVA has a long-term commitment to promoting responsible antimicrobial use throughout the profession and supporting EAAD through the PROTECT ME brand. This year we have released resources around Education, aimed at the profession through EVJ and to the horse owning public through development of material that can be provided alongside antimicrobial dispensing. The work of the equine profession in preserving the highest priority antimicrobials will ensure efficacy can be retained for as long as is possible."
The antimicrobial online collection is available free online at: http://onlinelibrary.wiley.com/journal/10.1001/(ISSN)2042-3306/homepage/antimicrobial_resistance.htm
Produced by Knowledge’s Library and Information Service, inFOCUS watches all relevant veterinary journals and provides concise summaries of the most important, interesting or practice-critical primary and secondary material.
Subscribers to inFOCUS are sent a bi-monthly email containing the summaries – including the bottom line for implementation in practice – and the option to read the original articles.
The new service aims to remove the time constraints associated with identifying the most vital research.
A Clinical Review Team, made up of experts and specialists from across the veterinary community, assesses journals to find the best items based on relevance, quality and potential impact, and then reviews and summarises the literature for each edition of inFOCUS.
RCVS President Stephen May said: "inFOCUS is a crucial and long-awaited provision available to everyone involved in veterinary care.
"By removing the barriers to accessing and reflecting upon latest research and commentary, this innovative way of bringing you must-know updates further enforces the move towards evidence-based veterinary medicine, of which RCVS Knowledge is a champion.
"Whether you’re someone who regularly checks veterinary publications or you rarely get the chance to analyse the available material, make sure inFOCUS is on your reading list."
As well as the six-times-per-year email, inFOCUS will be viewable online, where editions from previous months will be housed and individual summaries categorised by animal type. Though initially focused on small animals, literature from across the broad spectrum of veterinary practice will be highlighted.
You can subscribe here to have the latest inFOCUS updates sent directly to your inbox.
Also, if you're interested in helping to ensure that the most important research reaches the veterinary community, you can apply to join the Clinical Review Team here.
Leading human and animal health organisations – the British Medical Association (BMA), British Dental Association (BDA), British Veterinary Association (BVA) and Royal Pharmaceutical Society (RPS) - have joined forces for the first time to promote a ‘One Health’ approach to ensure responsible guardianship of antibiotics and their proper public use on European Antibiotics Awareness Day tomorrow.
Antibiotics are obviously a vital medicine for both animal and human health, and modern health systems rely on the availability and effectiveness of a range of antimicrobials to treat and prevent infections. Yet inappropriate use – such as prescribing for self-limiting infections, not finishing a prescribed course of antibiotics or habitual prophylactic use in healthy animals to prevent disease - all contribute to the development of resistant bacteria in both humans and animals.
Whilst antibiotic resistance in animals does not perhaps present the greatest immediate existential threat, there is a strong argument for a united message to the public coming from doctors, dentists, chemists and veterinary surgeons.
Quite simply, some 13M households own a pet. Pretty much all of them visit a vet at some stage, and most will be a human patient at some point in their lives. So, what a veterinary surgeon says about the use of antibiotics in animals has the potential to help transform how owners think about them when they come to visit the doctor.
A survey of general practitioner doctors last year found that 90% feel pressured by patients to prescribe antibiotics and 28% have prescribed them several times a week when not sure they are medically necessary. If veterinary surgeons refuse to prescribe them for pets unless medically necessary, explaining that they are a precious resource which can no longer be wasted, it could help relieve the pressure on doctors. The same goes for the importance of compliance; if owners learn the importance of their pet taking the full course, there's a greater chance they'll understand why they need to complete their own course of treatment.
BVA President Sean Wensley said: "Antimicrobial resistance (AMR) is too important an issue for uncoordinated approaches amongst the medical professions. We need to work together to share knowledge and successful approaches, as well as taking responsibility for not just the immediate clinical situations before us, but also for our role in supporting the health and wellbeing of wider society. An effective approach to tackling AMR is about professions and patients working together for the greater good."
BMA board of science Chair Professor Sheila the Baroness Hollins said: "Doctors have expressed significant concern about the threat of a ‘post-antimicrobial age’. It is vital that we see action to improve antimicrobial prescribing across all disciplines. Only by different professionals working together to improve antimicrobial stewardship will we start to address this major public health issue."
BDA President Professor Nairn Wilson said: "All health professionals have a responsibility to draw a line under inappropriate or unnecessary use of antibiotics. One in ten prescriptions in the UK are provided by dentists, so we’re determined to do our bit. We are facing a clear and present danger to public health, and it will only be overcome if we act together."
For further information about EAAD 2015, visit www.ecdc.europa.eu/en/EAAD
To mark EAAD 2015, BVA has produced a range of new posters to promote the responsible use of antibiotics for use in veterinary practices or as a source of information for pet owners which can be found on their website www.bva.co.uk/eaad.
322 farmers took part in the survey, 83% of which had a flock of over 100 ewes.
Three quarters of them had experienced abortions in their ewes during both the 2018/2019 and 2019/2020 lambing seasons. Of those that experienced abortions during the 2019/2020 lambing season, a quarter reported that the problem occurred in more than 2% of their flock and 44% of them did not ask their vet to investigate.
Katherine Timms, Ceva Animal Health’s ruminant veterinary advisor said: “Farmers who decide not to investigate why their ewes are aborting may well experience an abortion storm during the following year’s lambing season as Chlamydophila abortus, the bacteria that causes EAE, has the ability to lay latent in ewes until the next pregnancy.
“This means that one infected sheep shedding at lambing has the potential to infect multiple ewes that will almost certainly abort at their next lambing. The consequences can be financially and reproductively devastating for farmers and it’s advisable that vets raise awareness of EAE testing with their clients to help prevent this from happening. Ceva’s Assure Ewe programme offers farmers subsidised farm serology testing for Chlamydia abortus. Aborted ewes can be tested for Chlamydia abortus, ideally from three weeks to three months after lambing.”
Of the 47% of farmers that are not vaccinating against EAE, 57% said they would consider it. Reasons not to vaccinate included farmers believing that they had closed flocks (59%) and EAE not having been diagnosed (57%). Only 20% decided not to vaccinate because of cost and 25% because they did not feel it was worthwhile.
Ceva is continuing its ‘For Flock’s Sake – Vaccinate!’ initiative during 2021 to help raise awareness of EAE and highlight the importance of vaccination. This year, Ceva is also highlighting the importance of testing aborted ewes through its ‘For Flock’s Sake Get Tested’ campaign which encourages the submission of samples to a diagnostic laboratory or blood sampling after lambing has finished.
For more information, visit www.enzooticabortion.co.uk, contact your Ceva Animal Health account manager, call Ceva on 01494 781510 or email cevauk@ceva.com.
Photo: Ewe ewe looking at?
Alfaxan®, Vetoquinol's injectable general anaesthetic, is one year old this month. To celebrate the occasion, and the product's use by 860 UK practices in over 80,000 procedures so far, Vetoquinol is offering a free Alfaxan party bag.
The party bag includes an Alfaxan anaesthesia monitoring chart and an Alfaxan vet brochure with dosage chart and timer. In addition, everyone who claims a party bag will be entered into a lucky dip. Ten winners will be chosen at random to receive an oesophageal stethoscope kit, containing one normal stethoscope, with a removable head, and three Portex oesophageal stethoscope probes (small, medium and large) for monitoring patient’s heart and respiratory rate.
To claim your party bag, call the dedicated Alfaxan technical support line on 0800 345 7560 or email: MyAlfaxanPartyBag@vetoquinol.co.uk.
Vetoquinol also reports a very positive response to Alfaxan from the profession during its first year. Simon Boulton, one of Vetoquinol’s Veterinary Advisors, has been conducting wet labs across the country for the company. He said: "Vets have used the wet lab service to get me along to anaesthetize patients for the day using Alfaxan. I have had a great deal of positive feedback and the product is becoming more and more widely used. Extremely smooth and reliable inductions, followed by good cardiovascular and respiratory stability were the most noticeable features of Alfaxan anaesthesia, liked by both the vets anaesthetizing the patients and the nurses who monitor them."
The British Equine Veterinary Association's (BEVA) Equine Rescue Fund (ERF) has taken delivery of 'Howie the Rescue Horse', the UK's first lifesized model of a horse designed specially for training vets and firefighters
Howie will be used for the practical elements of the Rescue and Emergency Medicine Training for Equine Vets courses run by BEVA in partnership with Hampshire Fire and Rescue Service's animal rescue specialists. He will also be taken on the road to vet schools and be loaned to fire and rescue services wishing to train firefighters in manual emergency equine handling techniques.
Howie was designed to the animal rescue specialist's exacting specifications by Wales-based company Big Beasts, which more usually creates bespoke models, creatures, and props for the film and television industry, as well as for museums and theme parks.
Howie has been named after Genitrix' managing director, Howard Wilder after the company (which makes equine joint treatments such as irap HY-50®Vet) stepped in to cover the significant production costs of the model.
Howard said: "Horse rescue is a complex and hazardous operation, both for the animal and those trying to rescue it and treat any injuries. As a company actively involved in equine care, we felt it was important to make a significant financial contribution to the Equine Rescue Fund. It's great that Howie has safely arrived and we hope he'll prove an important asset to the ERF."
Picture shows: Howie the Rescue Horse with (left to right) Howard Wilder and Buster Brown and Jim Green, Animal Rescue Specialists, Hampshire Fire and Rescue Service
A new study from the University of Surrey, published today in the journal PLOS One, has identified the specific effects of a malformation which affects affects toy breeds.
According to researchers, Chiari malformation has become prevalent as a result of selective breeding and affects many toy dog breeds which have been bred to look more doll-like, including Griffon Bruxellois, Cavalier King Charles Spaniels, Chihuahuas and their crosses.
Researchers took brain, skull and vertebrae measurements of 155 Griffon Bruxellois and compared dogs affected by the condition with normal Griffons. They discovered that Griffons with the disease had taller foreheads and that it had also caused the shape of the brain to change, with severely affected animals having their cerebellum pushed underneath the main part of the brain.
The researchers say that although it can be asymptomatic, in many dogs Chiari malformation can cause headaches, problems with walking or even paralysis.
The condition can also affect humans and the University is working with human geneticists at the University of Montreal, in the hope that better understanding of the condition will lead to improved treatment for both dogs and humans.
Lead author, Dr Clare Rusbridge from the new School of Veterinary Medicine at the University of Surrey, said: "Chiari malformation can be described as trying to fit a big foot into a small shoe. It can be very painful, causing headaches and pressure on the brain and can result in fluid filled cavities in the spinal cord. Our latest discoveries will be significant in driving this research forward and hopefully allow us to identify which genes may be associated with the condition.
"Our next steps will be to apply our technique to other breeds with Chiari malformation and investigate more sophisticated ways of screening, so that risk of disease can be detected more easily, at an earlier age and with a single MRI scan.
"We want to engage breeders and give them practical advice about the condition, but it is also important that the public recognises that breeding dogs in a certain way to influence how they look might not be in the animal's best interest. There are responsible breeders out there, who have invested in screening and who are breeding for health as well as producing attractive puppies, and it is vital that people only look to buy from them."
Dr David Reese, Director of VetCT Australia and a Diplomate in veterinary diagnostic imaging will present: "Leveraging CT to Diagnose and Manage Unusual Pets", followed by a Q&A session.
David said: “This webinar is a fantastic opportunity to share knowledge about optimising imaging for exotic animals to reach an accurate diagnosis.
"The field of exotics imaging has rapidly advanced in recent years.
"With the increasing use of CT alongside traditional radiography, we can see so much more and provide high-quality reports to our client practices that empower them to give great care.
"We’re excited to support Exotic Vet Support with this CPD programme.”
Attendees will also receive an exclusive discount for the Exotic Vet Support Asia-Pacific (EVSAP) Conference 1st-2nd March 2024 in Sydney.
A recording of the webinar will be available after the live session, and for attendees of the EVSAP Conference.
Register here: https://vetct.zoom.us/webinar/register/WN_i_8KgMbPSeGZ-i7AbxaDqw#/registration
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
The RCVS Council has decided that the final enrolments for the remaining RCVS Diplomas must be made by 1 November 2012.
According to the College, this is in line with the recommendation made by the Education Policy and Specialisation Committee to Council that the RCVS should speed up the process of phasing out all of the remaining RCVS Diplomas in favour of the increasingly popular European Diplomas.
There are now such small numbers of candidates sitting RCVS Diploma exams that benchmarking and determining a consistent examination standard becomes increasingly difficult, and the examination increasingly indefensible and unsustainable. For example, in each of the past three years, only two candidates have entered the Diploma in Small Animal Surgery (Orthopaedics) exam, and there was only one candidate in 2008. Similarly, it is now usual for only one or two candidates per year to sit Diploma exams in Zoo Medicine, Cattle Health and Production or Ophthalmology.
A number of RCVS Diplomas have already been phased out, and new enrolments are no longer being taken in subjects such as Small Animal Medicine, Dermatology, Anaesthesia and Diagnostic Imaging.
Examinations will continue to be held for enrolled candidates (including candidates who enrol ahead of the 1 November 2012 deadline). The last Diploma examinations held in each subject will depend upon when its final candidates complete the pre-examination requirements. For candidates enrolling this year, this means 2019 at the latest.
The phasing out of RCVS Diplomas has been an agreed strategy of Council for many years after the then Education Strategy Steering Group recommended greater convergence with European Colleges in a report to Council in 2002 entitled "A framework for veterinary education and training for 2010 and beyond".
The position of each subject has been under review by the respective subject boards at their annual board meetings for the last few years, and some have already been closed to new entrants.
Professor Mike Herrtage, Chairman of the RCVS Diplomas and Certificates Subcommittee said: "For some subjects, there had been a perception that the European route required the candidate to follow a residency in an academic institution, which could be a barrier to UK practitioners' chances of completing a Diploma.
"However, all the European Colleges allow an alternate training route for practitioners provided the programme is planned and specified at the time of enrolment and approved by the College before training starts."
In some subjects, the European Diploma syllabus may not cover exactly the same ground as the RCVS equivalent - for example, small animal surgery encompasses both soft tissue surgery as well as orthopaedics - but the trend for residency positions in both universities and specialists practices has been to take candidates through the European style programmes, which produces more surgical specialists who thereafter can major in one aspect of another.
Mike said: "Recent experience has shown that many diplomates take the European Diploma first, and this entitles them to apply to join the list of RCVS Recognised Specialists. If they then want to specialise in a narrower field they can do so, by providing supporting data and references to show that they are practising at a specialist level in the area concerned."
Veterinary surgeons will continue to have multiple routes to RCVS Recognised Specialist status - including via European Diplomas, which also offer a route for those not in a standard residency position, American Diplomas, the RCVS Fellowship, or other such high level qualifications.
A study published by Mike Dryden - one of the world's leading parasitologists - in Veterinary Parasitology has demonstrated that spinosad (Comfortis, Elanco) provides a high level of flea control one month after a single treatment and maintains a high level of effectiveness under conditions of natural challenge following subsequent monthly treatments.
The multi-clinic, investigator-blinded study1 was undertaken in client-owned dogs provided with three consecutive monthly treatments of oral spinosad (SPN) and fipronil/methoprene spot-on (FSM). All other household dogs and cats, to a maximum of four pets per household, were dispensed the same treatment. Subsequent treatments were given when the dog returned for whole-body flea counts and pruritus-scoring on days 30 and 60, with final assessments on day 90 (plus/minus five days on each occasion).
One hundred and twenty eight dogs were enrolled on the study at 10 veterinary practices in the USA (65 in the SPN arm and 63 in the FSM arm). On day 0, mean flea counts were 57.7 (range: 10-1469) and 44.8 (range: 10-717) for the SPN and FSM groups, respectively. On day 90, 55 of the 58 (95%) SPN dogs were flea free compared with only 21/55 or 38% of dogs in the FSM group. Mean pruritus scores declined to 0.92 (6.67 on day 0) in the SPN group and 3.83 (6.33 on day 0) in the FSM group by day 90. Mean flea counts were 0.08 and 5.19 for SPN and FSM groups respectively on day 90 correlating to a reduction in flea counts of 99.9% in the SPN dogs and 88.4% in the FSM dogs. Between treatment differences were found to be highly statistically significant (p<0.0001) for every parameter measured at every time point during the study in favour of SPN.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "The recent study confirms oral spinosad's outstanding efficacy in controlling fleas and associated pruritus in dogs when administered by owners following natural challenge in the home environment".
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
1 Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Michael W. Dryden, William G. Ryan, Margie Bell, Anthony J. Rumschlag, Lisa M. Young, Daniel E. Snyder. Veterinary Parasitology 191 (2013) 340-346
The PDSA has announced that it is offering free workshops to help veterinary professionals deliver new welfare checks called 'PetWise MOTs'.
The PetWise MOT checks focus on the five welfare needs, and the workshops count for seven hours CPD. The charity says that while the workshops are suitable for all members of the practice team, they should be of particular interest to nursing teams and those with a keen interest in engaging clients with the needs of their pets.
The aim of the MOT Checks is to improve pet wellbeing in the UK, following reports of a reduced level of awareness amongst the public of the five welfare needs defined by the Animal Welfare Acts.
Richard Casey, PDSA Pet Wellbeing Project Manager, said: "We know there is more to a pet’s wellbeing than just providing for their basic health needs. This unique consultation structure was developed in response to falling awareness among owners of their pets’ welfare needs, with millions of pets suffering unnecessarily. The PetWise MOTs use a simple traffic light system and personalised action plans to reverse this trend by helping to inform and engage owners about what their pets need to be healthy and happy."
The consultations were first trialled on the charity’s mobile PetCheck vehicles, then expanded to PDSA’s 51 pet hospitals. According to the charity, over 100,000 PetWise MOTs and follow up checks have now been completed in the last few years, with outcomes including:
Alison Case, a Senior Vet at Bow PDSA Pet Hospital, said: "PetWise MOTs give a really practical approach to running clinics based on the pet’s welfare needs. We’ve seen a positive impact on patient care by looking at husbandry at home as well as the clinical concerns of the patient. The consultations help to strengthen the clinic-client bond through professional support and advice. We’ve had great feedback from our clients, who are now much more aware of the routine needs of their pets and often attend for further check-ups as well as regularly purchasing preventive treatments."
The workshops will focus on dogs, cats and rabbits, although the consultations are transferable to all species.
For more information or to book a place, visit www.pdsa.org.uk/petwise or email petwise@pdsa.org.uk.
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
Amy Bergs MRCVS, owner of The Cat Doctor in Surrey and co-founder of the new British Mobile Veterinary Association, has won a week's worth of free advertising for her practice on national TV.
The competition was run by the mobile payments company iZettle, which invited entrants to submit a 15 minute video about their business.
Amy's husband and business partner Robert put the video entry together. It was one of seven winners picked out of hundreds that iZettle said it received.
The resulting advert (below) is being shown on a number of TV channels, including Sky News, Sky Sports and Comedy Central, from today.
Amy said: "We are so excited to have won the competition. We love what we do and would like to help more cats, it’s such an amazing opportunity to share what we can offer on national television!"
watch?v=Vi8SCWcPJoo